Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson & Johnson’s Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).
The team compared the SARS-CoV-2 infection rate among more than 1,700 individuals who received one vaccine shot with the rate among more than 17,700 unvaccinated, propensity-matched controls.
- General23 hours ago
Spectator Australia TV: The budget horrow show
- Sport13 hours ago
Independent Match Review Panel to investigate Wellington’s goal celebration – NEWS.com.au
- Health22 hours ago
Melbourne man diagnosed with cancer thought he had a pimple or ‘infected boil’ – 9News
- Health15 hours ago
Why ADHD went viral on TikTok (and then became annoying) – Mashable